Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
190774-54-0O=C=Nc1ccc(F)cc1C(F)(F)FMNANIHSTOUUFNY-UHFFFAOYSA-N190774-54-0DTXSID40369880Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Danger
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal];H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]
P260, P261, P264, P270, P271, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Verwenden4-Fluoro-2-(trifluoromethyl)phenyl Isocyanate is a reagent used for the preparation of nitrogen-containing compounds having kinase inhibitory activity. More specifically, 4-Fluoro-2-(trifluoromethyl)phenyl Isocyanate can be used for the preparation of ureas and related compounds as KDR kinase inhibitors for the treatment of some cancers.
Wird geladen…